| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.19B | 10.13B | 12.49B | 8.70B | 6.83B |
| Gross Profit | 3.88B | 3.86B | 1.93B | 1.74B | 2.10B |
| EBITDA | 3.11B | 3.23B | 189.10M | 4.32B | 3.30B |
| Net Income | 1.21B | 1.19B | -158.00M | 3.03B | 2.28B |
Balance Sheet | |||||
| Total Assets | 35.35B | 30.36B | 27.14B | 25.76B | 21.59B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 1.09B | 1.21B | 1.13B | 1.60B |
| Total Debt | 13.11B | 10.60B | 10.94B | 10.19B | 10.88B |
| Total Liabilities | 21.94B | 17.67B | 17.91B | 17.64B | 16.38B |
| Stockholders Equity | 12.66B | 12.06B | 8.58B | 8.08B | 5.21B |
Cash Flow | |||||
| Free Cash Flow | -711.80M | -654.20M | -360.90M | 121.40M | 593.30M |
| Operating Cash Flow | 3.44B | 2.48B | 1.46B | 1.58B | 1.77B |
| Investing Cash Flow | -4.62B | -3.32B | -2.96B | -744.90M | 443.70M |
| Financing Cash Flow | 1.64B | 896.20M | 1.35B | -1.38B | -778.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £2.70B | 47.06 | 3.94% | 2.78% | -11.94% | -84.94% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £783.68M | 11.86 | 27.40% | 7.01% | 1.71% | -12.49% | |
62 Neutral | £59.66B | 18.68 | 8.47% | 4.15% | -3.76% | 8.20% | |
59 Neutral | £28.78B | 23.95 | 9.45% | 2.98% | 0.54% | -5.54% | |
59 Neutral | £8.53B | 40.73 | 1.68% | 2.86% | -2.11% | -104.48% | |
58 Neutral | £19.15M | -0.99 | -68.06% | ― | -60.76% | -230.39% |